• No results found

[PDF] Top 20 Formulation and in-vitro evaluation of stavudine extended release tablets

Has 10000 "Formulation and in-vitro evaluation of stavudine extended release tablets" found on our website. Below are the top 20 most common "Formulation and in-vitro evaluation of stavudine extended release tablets".

Formulation and in-vitro evaluation of stavudine extended release tablets

Formulation and in-vitro evaluation of stavudine extended release tablets

... Solid dosage forms are popular because of ease of administration, self-medication, pain avoidance as compared with parenteral, and low cost. [1] One of the most common approaches used for prolonging and controlling the ... See full document

11

Formulation and in vitro evaluation of alfuzosin extended release tablets using directly compressible eudragit

Formulation and in vitro evaluation of alfuzosin extended release tablets using directly compressible eudragit

... of formulation factors and the in vitro evaluation of an extended release dosage form of a freely soluble weakly basic drug (alfuzosin ...in tablets prepared by direct ... See full document

7

Formulation and in vitro evaluation of controlled release matrix tablets of nicotinic acid using xyloglucon and other hydrphilic polymers

Formulation and in vitro evaluation of controlled release matrix tablets of nicotinic acid using xyloglucon and other hydrphilic polymers

... drug release was more by diffusion and less by ...and release rate of NA. Increase in the amount of gum in the formulation from 50%w/w to 150%w/w, resulted in slower rate, and decreased the amount of ... See full document

6

FORMULATION AND IN-VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LEVOFLOXACIN

FORMULATION AND IN-VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LEVOFLOXACIN

... drug release from the matrix system, the in vitro release rate were fitted to Korsmeyer-peppas model and interpretation of release exponent value (n) enlighten in understanding the ... See full document

9

Formulation and In-vitro evaluation of immediate release Olanzapine tablets

Formulation and In-vitro evaluation of immediate release Olanzapine tablets

... Olanzapine tablets 20mg were prepared using the above mentioned superdisintegrants and the invitro dissolution profiles of the formulations were compared with that of marketed formulation Zyprexa ...The ... See full document

12

Formulation Development and  In-vitro Evaluation of Sustained Release Tablets of Carvedilol Solid Dispersion

Formulation Development and In-vitro Evaluation of Sustained Release Tablets of Carvedilol Solid Dispersion

... sustained release tablets of Carvedilol by solid dispersion technique for improving solubility of Carvedilol using Poloxamer 407 and PVP ...carvedilol tablets were prepared by direct compression ... See full document

10

Formulation and In-Vitro Evaluation of Extended Release Matrix Tablets of Trimetazidine HCL

Formulation and In-Vitro Evaluation of Extended Release Matrix Tablets of Trimetazidine HCL

... characterize extended-release matrix tablets of zidovudine using hydrophilic Eudragit RLPO and RSPO alone or their combination with hydrophobic ethyl ...cellulose. Release kinetics was ... See full document

114

Formulation Development and In-Vitro Evaluation of
Potassium Chloride Extended Release Tablets

Formulation Development and In-Vitro Evaluation of Potassium Chloride Extended Release Tablets

... particles. Tablets require the flow of the correct weight of material into a specific volume, the behaviour of the material under pressure is important; and the wetting of the powder is also critical for ... See full document

90

GEOMATRIX TECHNOLOGY: FORMULATION AND EVALUATION OF STAVUDINE EXTENDED RELEASE TABLETS

GEOMATRIX TECHNOLOGY: FORMULATION AND EVALUATION OF STAVUDINE EXTENDED RELEASE TABLETS

... sustained release formulation of Stavudine is ...drug release is to include it in a matrix ...drug release profile, cost effectiveness, and broad regulatory ...[16] Stavudine is ... See full document

12

Development of sustained release formulation of glipizide using natural polymer from Tamrindus indica for better patient compliance

Development of sustained release formulation of glipizide using natural polymer from Tamrindus indica for better patient compliance

... 13. Narasimha Reddy D., Srinath M S., Abdul Ahad H, Kishore Kumar Reddy B., Vamsi Krishna Reddy P., Krishna Mahesh Ch., Kranthi G., Raghavendra P. Formulation and in-vitro Evaluation of Glimepiride ... See full document

6

FORMULATION DESIGN AND EVALUATION OF NON EFFERVACENT FLOATING TABLETS OF GLICLAZIDEMangulal KethavathDOWNLOAD/VIEW

FORMULATION DESIGN AND EVALUATION OF NON EFFERVACENT FLOATING TABLETS OF GLICLAZIDEMangulal KethavathDOWNLOAD/VIEW

... matrix tablets of diltiazem ...Ram2,. Formulation and in-vitro evaluation gastroretentive drug delivery system of Cefixime for prolong ... See full document

8

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF TAPENTADOL HCl

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF TAPENTADOL HCl

... 7. Huijun Xie, Yong Gan, Suwei Ma, Li Gan and Qinghua Chen, this review give the information about the Optimization and Evaluation of Time Dependent Tablets Comprising an Immediate and Sustained ... See full document

11

Formulation and Evaluation of Extended Release Metoprolol Succinate Matrix Tablets.

Formulation and Evaluation of Extended Release Metoprolol Succinate Matrix Tablets.

... Controlled release drug delivery systems are designed by different techniques like enteric coating, osmotic pump, pro drugs, transdermal patches and matrix ...matrix tablets because of their ease of ...the ... See full document

145

FORMULATION AND EVALUATION OF EXTENDED RELEASE MATRIX TABLETS OF DESVENLAFAXINE SUCCINATE

FORMULATION AND EVALUATION OF EXTENDED RELEASE MATRIX TABLETS OF DESVENLAFAXINE SUCCINATE

... of weight Diameter Thickness Hardness Friability F1 370+0.92 10.2+0.04 4.3+0.06 6.8+0.2 0.12 % F2 370+0.84 10.2+0.06 4.3+0.07 8.2+0.4 0.13 % F3 370+1.04 10.2+0.07 4.3+0.08 6.2+0.6 Nil F4 370+1.06 10.2+0.06 4.3+0.07 ... See full document

9

Formulation and Evaluation of Extended Release Matrix Tablets of Trimetazidine Dihydrochloride.

Formulation and Evaluation of Extended Release Matrix Tablets of Trimetazidine Dihydrochloride.

... burst release due to the presence of the drug on the surface of the matrix ...successful extended release of drugs, it is essential that polymer hydration and surface gel layer formation are quick so ... See full document

126

FORMULATION DEVELOPMENT AND EVALUATION OF POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS

FORMULATION DEVELOPMENT AND EVALUATION OF POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS

... rapid release, it causes local tissue irritation in the ...an extended release ...ER tablets, a few critical factors were ...the formulation using hydrophobic polymers ...various ... See full document

13

FORMULATION AND EVALUATION OF MEFENAMIC ACID EXTENDED RELEASE LIQUISOLID TABLETS

FORMULATION AND EVALUATION OF MEFENAMIC ACID EXTENDED RELEASE LIQUISOLID TABLETS

... The studies were done on eight station USP dissolution apparatus I (Lab India). All batches of tablets were evaluated using 900 ml of sequential gastrointestinal release medium, i.e. 0.1N hydrochloric acid ... See full document

17

“FORMULATION AND EVALUATION OF EXTENDED RELEASE DOSAGE FORM OF METFORMIN HYDROCHLORIDE USING A COMBINED HYDROPHOBIC AND HYDOPHILIC MATRIX: RATE OF IN-VITRO AND IN-VIVO RELEASE STUDIES” by K. Sundaramoorthy* and S. Kavimani, India.

“FORMULATION AND EVALUATION OF EXTENDED RELEASE DOSAGE FORM OF METFORMIN HYDROCHLORIDE USING A COMBINED HYDROPHOBIC AND HYDOPHILIC MATRIX: RATE OF IN-VITRO AND IN-VIVO RELEASE STUDIES” by K. Sundaramoorthy* and S. Kavimani, India.

... pharmaceutical formulation of metformin hydrochloride in order to achieve an optimal ...on extended release of drug including the sophisticated gastro retentive system 3-7 ... See full document

9

Formulation and Evaluation of Acetaminophen and Diphenhydramine Hydrochloride Tablets.

Formulation and Evaluation of Acetaminophen and Diphenhydramine Hydrochloride Tablets.

... Acetaminophen is the active metabolite of phenacetin. Acetaminophen possesses analgesic and antipyretic activity however, some clinicians consider Acetaminophen a poor analgesic. Since Acetaminophen has no peripheral ... See full document

129

Formulation and evaluation of Ropinirole Hcl extended release matrix tablets

Formulation and evaluation of Ropinirole Hcl extended release matrix tablets

... The development of an extended release tablets for a drug having high solubility is an approach to obtain a controlled release. In one strategy, matrix formers are Guar gum, Sodium alginate, ... See full document

10

Show all 10000 documents...